Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience
Abstract There are few published data on long-term treatment with sirolimus in lymphangioleiomyomatosis (LAM). The objective of this study was to describe the long-term effect of sirolimus in a series of LAM patients followed up in a referral centre, focusing on pulmonary function. We retrospectivel...
Guardado en:
Autores principales: | Eva Revilla-López, Cristina Berastegui, Alejandra Méndez, Berta Sáez-Giménez, Victoria Ruiz de Miguel, Manuel López-Meseguer, Victor Monforte, Carlos Bravo, Miguel Angel Pujana, Maria Antonia Ramon, Susana Gómez-Ollés, Antonio Roman, The Vall d’Hebron Multidisciplinary Cystic Lung Disease Group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d41b30c353e24ea39210f9e0a6644bc1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis
por: Teiko Sakurai, et al.
Publicado: (2021) -
Uncommon radiologic computed tomography appearances of the chest in patients with lymphangioleiomyomatosis
por: Yasuhito Sekimoto, et al.
Publicado: (2021) -
Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis
por: Koichi Nishino, et al.
Publicado: (2021) -
Optimized formulation of solid self-microemulsifying sirolimus delivery systems
por: Cho W, et al.
Publicado: (2013) -
Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina M, et al.
Publicado: (2011)